chlorfenson

Chlorfenson is a small molecule antifungal agent developed by Moberg Derma, primarily indicated for the treatment of onychomycosis (nail fungus)[2][3][7]. It is typically formulated as a topical solution applied once daily to affected nails over treatment periods of 3–6 months[2][5]. Chlorfenson acts by disrupting fungal cell membranes, thereby inhibiting fungal growth and reproduction[5]. In addition to its antifungal use, it has also been described as an insecticide with ovicidal and larvicidal activity against certain mite species[5]. Pilot studies have shown promising results for onychomycosis, offering an alternative to oral antifungals that carry higher risks of severe side effects in more advanced cases[2][7].

Brand names

ORTHOTRANOVOCHLOR

Other names

4-chlorophenyl 4-chlorobenzenesulfonateester sulfonatechlorfenson